Assessing the effectiveness of azvudine and paxlovid in hospitalized COVID-19 patients aged over 60
Coronavirus
Compuscript Ltd Apr 14 2025 This new article publication from Acta Pharmaceutica Sinica B , discusses a retrospective cohort study of the efficacy and safety of oral azvudine versus nirmatrelvir/ritonavir in elderly hospitalized COVID-19 patients aged over 60 years. Azvudine and nirmatrelvir/ritonavir (Paxlovid) are recommended for COVID-19 treatment in China, but their safety and efficacy in the elderly population are not fully known. In this multicenter, retrospective, cohort study, the
din zilele anterioare